Navigation Links
Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting

Diversity of Abstracts Reflects Continued Growth of Eisai's Commitment to Oncology

WOODCLIFF LAKE, N.J., May 31, 2007 /PRNewswire/ -- Eisai announced today that several abstracts covering clinical data about their oncology pipeline compounds have been accepted for presentation at the American Society of Clinical Oncology (ASCO) annual meeting. ASCO takes place in Chicago from June 1-5, 2007.

These abstracts reveal a growing and diverse oncology clinical development program at Eisai. In addition to the variety of oncology product classes under investigation, these compounds are being studied in advanced diseases where there remains considerable unmet medical need, particularly in refractory metastatic breast cancer, advanced non-small cell lung cancer, and advanced ovarian cancer.

The following abstracts highlight data from pipeline compounds that have been accepted for presentation at this year's ASCO meeting.


    Product        Abstract Details                        Location Details


    Eribulin       Phase II Study of Eribulin Mesylate     June 2, 2007 8:00

    Mesylate       (E7389) Halichondrin B Analog in        AM - 1:00 PM

    (E7389)        Patients with Refractory Breast Cancer  Location: S403

    Abstract No:   Poster Number: 21

    1034



    Eribulin       Phase II Study of Eribulin Mesylate     June 2, 2007 8:00

    Mesylate       (E7389), a Mechanistically Novel        AM - 1:00 PM

    (E7389)        Inhibitor of Microtubule Dynamics,      Location: E451a

    Abstract No:   in Patients with Advanced Non-Small

    7546           Cell Lung Cancer (nsclc)

                   Poster Number: 20



    MORAb-003      Novel Phase II Study Design of          June 2, 2007

    Abstract No:   MORAb-003, a Monoclonal Antibody        2:00 PM - 6:00 PM

    5583           against Folate Receptor Alpha in        Location: S Hall A2

                   Platinum-Sensitive Ovarian Cancer

                   in First Relapse

    
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:7/11/2014)... , July 11, 2014 ... visitors to Safety & Health Expo 2014 ... the move to London ... management attending exhibition.     ... http://photos.prnewswire.com/prnh/20140711/696892-a )      ...
(Date:7/10/2014)... July 10, 2014  The U.S. Department of Health ... to University Hospitals (UH) Case Medical Center Seidman Cancer ... model aimed at improving care for patients with complex ... project will test a unique model developed at UH ... disease, significant comorbidities, or demonstrated need for high health ...
(Date:7/10/2014)... Pa. , July 10, 2014 ... Moberg Research,s (Moberg) medical device manufacturing facility. Rep. ... Moberg,s advanced neurological monitors facilitate cutting-edge research in ... Rep. Kennedy and mental health advocate, Garen ... organization dedicated to fostering fundamental changes that will ...
Breaking Medicine Technology:UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2
(Date:7/13/2014)... Recently, MillionaireCasket.com, a well-known casket manufacturer from China, has ... the company’s chief executive officer has announced a new promotion ... offered at discounted prices, from 15 to 26 percent off. ... in huge demand in the current market. We are excited ... a lot of high quality products for sale. Many of ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 The North American ... million in 2013 to $5,450 million by 2018, at a ... systems market is expanding at a rapid pace in North ... ever tightening laws on water & wastewater storage and collection, ... infrastructure. The market is expanding at a healthy rate in ...
(Date:7/13/2014)... The report “Micronutrient Market by Type (Zinc, Manganese, ... Chelated), Application Mode (Soil, Foliar, Fertigation), Crop Type ... 2018” defines and segments the global agriculture micronutrients ... global value and volume for agriculture micronutrients. It ... the global agriculture micronutrients market with an analysis ...
(Date:7/13/2014)... Fuel additives are chemicals, which are added to various ... so on, in order to enhance their performance. Fuel ... caused by fuels and improving the combustion properties of ... of scale in the long run, but, in the ... fuel products. , The various fuel additive types include ...
(Date:7/13/2014)... MarketsandMarkets recently conducted a study on ... 3D rendering; Layout and Animation; Image Reconstruction]: Global ... which analyzes and studies the major market drivers, ... Eastern Europe, Middle East and Africa, Asia-Pacific and ... landscape of the 3D imaging market, providing an ...
Breaking Medicine News(10 mins):Health News:Cheap Oak Caskets Recently Unveiled By China Casket Manufacturer MillionaireCasket.com 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 2Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 4Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4
... breast cancer be putting her at higher risk for ... women who underwent simple mastectomy and radiotherapy for their ... radical mastectomy and no radiotherapy to later develop lung ... were noted among a group of women who had ...
... Since the start in recent years of intense genetic sequencing, ... the study appearing this week in the journal Science is ... standard size poodle named Shadow, the family pet of gene ... to sequence the canine genes. ,"Shadow is now ...
... intensity will not significantly increase the amount of weight ... exercise is necessary to help long-term weight loss, the ... loss has not been established. However, //it has been ... may improve long-term weight loss. ,Researchers from ...
... the brain become blocked. A silent stroke does not cause ... risk of a future stroke.// A new study shows having ... a silent stroke. ,For the study, researchers conducted MRIs ... of the patients had high blood pressure but did not ...
... male and over age 34 are at the greatest risk ... importance of discontinuing drug-use among older drug users.// ,Recognizing ... sectors to help them. A study conducted by researchers in ... greatest risk of death. Researchers looked at the drug-related deaths ...
... for weight loss has become a popular trend, but a ... say people should not assume herbal weight loss aids are ... they are not subject to the same standards as drugs. ... problems after taking Chaso and Onshido -- two popular herbal ...
Cached Medicine News:Health News:Dog DNA reveals man's link with best friend, 2Health News:Risks for Silent Strokes 2
7 1/2" Bayonet Monopolar Forceps, Ins., Serrated...
Extended blade - 25/box....
... and workmanship are the hallmark of these ... in mind. The top (incident) circular 9W ... shadows while remaining cool to the touch. ... with 10x to 44x zoom magnification or ...
... Nikon's evanescent wave imaging system utilizes ... molecules in the thin section in ... structure". This unique design permits simultaneous ... illumination systems, with no restriction on ...
Medicine Products: